In:
Tropical Medicine and Infectious Disease, MDPI AG, Vol. 6, No. 1 ( 2021-01-24), p. 13-
Abstract:
In Mali, since 2007, artemether-lumefantrine has been the first choice against uncomplicated malaria. Despite its effectiveness, a rapid selection of markers of resistance to partner drugs has been documented. This work evaluated the treatment according to the World Health Organization’s standard 28-day treatment method. The primary endpoint was the clinical and parasitological response corrected by a polymerase chain reaction. It was more than 99.9 percent, the proportion of patients with anemia significantly decrease compared to baseline (p 〈 0.001), and no serious events were recorded. Plasmodium falciparum remains sensitive to artemether-lumefantrine in Mali.
Type of Medium:
Online Resource
ISSN:
2414-6366
DOI:
10.3390/tropicalmed6010013
Language:
English
Publisher:
MDPI AG
Publication Date:
2021
detail.hit.zdb_id:
2934690-3
Permalink